Because we were interested in studying Snai1 as a potential target for tumor vascular re-engineering in a therapeutic setting, we decided on generating mice heterozygous for Snai1 instead of a complete, homozygous knock-out. The gene discussed is SNAI1; the disease is neoplasm.